C3.ai's management is extremely bullish on a recent agreement the company reached with Microsoft. The deal could lead to significant growth opportunities for C3.ai. What impact the agreement will ...

C3.ai (NYSE: AI) is an artificial intelligence (AI) company that has captivated many investors in recent years due to the potential for this mid-cap stock to be the next big tech company.

Following the rupture of cerebral blood vessels, blood metabolites activate resident immune cells such as microglia and astrocytes, and infiltrate peripheral immune cells, leading to the release of a ...

These oligos provide poly-dT sequences to capture mRNAs released after cell lysis inside the droplets and cell-specific and transcript-specific barcodes (16 bp 10×barcodes and 10 bp unique molecular ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

In the same way that ChatGPT understands human language, a new AI model developed by computational biologists captures the language of cells to accurately predict their activities. In the same way ...

During C3.ai's second quarter of fiscal 2025 (ended Oct. 31), the company closed more than 60% of its deals through this partner ecosystem. Working with a broad array of big tech firms and ...

One of the company's more formidable competitors is C3.ai, which is currently growing at a similar rate to that of Palantir. While C3.ai is flying under the radar for now, the company could emerge ...

In this multiplex screening approach, cells are made to express a drug target of interest (e.g., viral protease), which causes a growth defect that can be rescued upon growing the cells in the ...

Share on Pinterest Do all our cells have a type of memory, and if so, how might this influence health? We investigate. Design by MNT; Photography by Grant Faint/Getty Images & Ed Reschke/Getty Images.